ATM and neoplasm: Regarding the role of ATM mutations on the efficacy of therapeutic strategies, it is well known that activation of the ATM-dependent pathway in tumor cells can promote chemoresistance and radiotherapy resistance through the activation of p38 MAPK and enzyme transglutaminase 2 [3,26], as well as by inducing enzymes involved in DNA double-strand break (DSB) repair [27].